A detailed history of Sigma Planning Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sigma Planning Corp holds 54,556 shares of BMY stock, worth $2.21 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
54,556
Previous 22,610 141.29%
Holding current value
$2.21 Million
Previous $1.16 Million 155.0%
% of portfolio
0.1%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $1.53 Million - $1.74 Million
31,946 Added 141.29%
54,556 $2.96 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $2.12 Million - $2.53 Million
-43,690 Reduced 65.9%
22,610 $1.16 Million
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $111,322 - $124,475
-1,923 Reduced 2.82%
66,300 $3.85 Million
Q2 2023

Aug 01, 2023

SELL
$63.71 - $70.74 $746,044 - $828,365
-11,710 Reduced 14.65%
68,223 $4.36 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $150,410 - $170,599
-2,289 Reduced 2.78%
79,933 $5.54 Million
Q4 2022

Jan 24, 2023

SELL
$68.48 - $81.09 $106,212 - $125,770
-1,551 Reduced 1.85%
82,222 $0
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $1,063 - $628,397
-8,178 Reduced 8.89%
83,773 $5.96 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $505,798 - $557,060
6,965 Added 8.2%
91,951 $7.08 Million
Q1 2022

Apr 20, 2022

SELL
$61.48 - $73.72 $118,840 - $142,500
-1,933 Reduced 2.22%
84,986 $6.21 Million
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $239,350 - $279,026
-4,463 Reduced 4.88%
86,919 $5.42 Million
Q3 2021

Oct 28, 2021

BUY
$59.17 - $69.31 $367,623 - $430,623
6,213 Added 7.29%
91,382 $5.41 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $44,637 - $48,609
-721 Reduced 0.84%
85,169 $5.69 Million
Q1 2021

May 06, 2021

BUY
$59.34 - $66.74 $274,625 - $308,872
4,628 Added 5.7%
85,890 $5.42 Million
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $168,427 - $190,859
-2,917 Reduced 3.47%
81,262 $5.04 Million
Q3 2020

Nov 03, 2020

BUY
$57.43 - $63.64 $293,467 - $325,200
5,110 Added 6.46%
84,179 $5.08 Million
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $1.09 Million - $1.27 Million
19,799 Added 33.4%
79,069 $4.65 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $169,870 - $246,861
3,661 Added 6.58%
59,270 $3.3 Million
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $887,059 - $1.16 Million
18,026 Added 47.96%
55,609 $3.57 Million
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $264,532 - $313,641
6,185 Added 19.7%
37,583 $1.91 Million
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $409,522 - $452,842
9,178 Added 41.31%
31,398 $1.42 Million
Q1 2019

May 01, 2019

SELL
$45.12 - $53.8 $21,612 - $25,770
-479 Reduced 2.11%
22,220 $1.06 Million
Q4 2018

Jan 31, 2019

SELL
$48.76 - $63.23 $15,066 - $19,538
-309 Reduced 1.34%
22,699 $1.18 Million
Q3 2018

Nov 07, 2018

SELL
$55.19 - $62.25 $7,064 - $7,968
-128 Reduced 0.55%
23,008 $1.43 Million
Q2 2018

Aug 02, 2018

BUY
$50.53 - $62.98 $7,427 - $9,258
147 Added 0.64%
23,136 $1.28 Million
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $6,591 - $7,587
-110 Reduced 0.48%
22,989 $1.45 Million
Q4 2017

Feb 07, 2018

SELL
$59.94 - $65.35 $704,594 - $768,189
-11,755 Reduced 33.73%
23,099 $1.42 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $1.92 Million - $2.22 Million
34,854
34,854 $2.22 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.